| Neonatal sunburn and melanoma in mice FP Noonan, JA Recio, H Takayama, P Duray, MR Anver, WL Rush, ... Nature 413 (6853), 271-272, 2001 | 455 | 2001 |
| Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1 JA Recio, G Merlino Oncogene 21 (7), 1000-1008, 2002 | 209 | 2002 |
| Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis R Sharp, JA Recio, C Jhappan, T Otsuka, S Liu, Y Yu, W Liu, M Anver, ... Nature medicine 8 (11), 1276-1280, 2002 | 171 | 2002 |
| Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF P Andreu-Pérez, R Esteve-Puig, C de Torre-Minguela, M López-Fauqued, ... Science signaling 4 (190), ra58-ra58, 2011 | 161 | 2011 |
| Uncoupling of the LKB1-AMPKα Energy Sensor Pathway by Growth Factors and Oncogenic BRAFV600E R Esteve-Puig, F Canals, N Colome, G Merlino, JA Recio PloS one 4 (3), e4771, 2009 | 123 | 2009 |
| Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis JA Recio, FP Noonan, H Takayama, MR Anver, P Duray, WL Rush, ... Cancer research 62 (22), 6724-6730, 2002 | 119 | 2002 |
| Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations F Niehr, E von Euw, N Attar, D Guo, D Matsunaga, H Sazegar, C Ng, ... Journal of translational medicine 9, 1-13, 2011 | 114 | 2011 |
| TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence I Puig, SP Tenbaum, I Chicote, O Arques, J Martinez-Quintanilla, ... The Journal of clinical investigation 128 (9), 3887-3905, 2018 | 98 | 2018 |
| Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1 JA Recio, G Merlino Cancer research 63 (7), 1576-1582, 2003 | 97 | 2003 |
| Early evolutionary divergence between papillary and anaplastic thyroid cancers J Capdevila, R Mayor, FM Mancuso, C Iglesias, G Caratù, I Matos, ... Annals of Oncology 29 (6), 1454-1460, 2018 | 57 | 2018 |
| The dual PI3K/mTOR inhibitor PI‐103 promotes immunosuppression, in vivo tumor growth and increases survival of sorafenib‐treated melanoma cells M López‐Fauqued, R Gil, J Grueso, J Hernandez‐Losa, A Pujol, T Moliné, ... International journal of cancer 126 (7), 1549-1561, 2010 | 54 | 2010 |
| ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment M Pérez-Alea, K McGrail, S Sánchez-Redondo, B Ferrer, G Fournet, ... Oncogene 36 (41), 5695-5708, 2017 | 52 | 2017 |
| Epidermal growth factor receptor signaling in hepatocellular carcinoma: inflammatory activation and a new intracellular regulatory mechanism C Berasain, A Nicou, O Garcia-Irigoyen, MU Latasa, R Urtasun, ... Digestive Diseases 30 (5), 524-531, 2012 | 46 | 2012 |
| Identity between the PCPH proto-oncogene and the CD39L4 (ENTPD5) ectonucleoside triphosphate diphosphohydrolase gene JG Paez, JA Recio, A Rouzaut, V Notario International journal of oncology 19 (6), 1249-1254, 2001 | 45 | 2001 |
| Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivotumor growth P Andreu-Pérez, J Hernandez-Losa, T Moliné, R Gil, J Grueso, A Pujol, ... BMC cancer 10, 1-11, 2010 | 44 | 2010 |
| New approach to cancer therapy based on a molecularly defined cancer classification J Cortés, E Calvo, A Vivancos, J Perez‐Garcia, JA Recio, J Seoane CA: a cancer journal for clinicians 64 (1), 70-74, 2014 | 43 | 2014 |
| A Mouse Model Uncovers LKB1 as an UVB-Induced DNA Damage Sensor Mediating CDKN1A (p21WAF1/CIP1) Degradation R Esteve-Puig, R Gil, E Gonzalez-Sanchez, JJ Bech-Serra, J Grueso, ... PLoS genetics 10 (10), e1004721, 2014 | 41 | 2014 |
| Oral Methylthioadenosine Administration Attenuates Fibrosis and Chronic Liver Disease Progression in Mdr2−/− Mice MU Latasa, C Gil-Puig, MG Fernandez-Barrena, CM Rodriguez-Ortigosa, ... PloS one 5 (12), e15690, 2010 | 32 | 2010 |
| Genetic evolution of nevus of Ota reveals clonal heterogeneity acquiring BAP1 and TP53 mutations A Vivancos, G Caratú, J Matito, E Muñoz, B Ferrer, J Hernández‐Losa, ... Pigment Cell & Melanoma Research 29 (2), 247-253, 2016 | 27 | 2016 |
| Both normal and transforming PCPH proteins have guanosine diphosphatase activity but only the oncoprotein cooperates with Ras in activating extracellular signal-regulated … JA Recio, JG Páez, B Maskeri, M Loveland, JA Velasco, V Notario Cancer research 60 (6), 1720-1728, 2000 | 26 | 2000 |
